Literature DB >> 11880644

Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.

Aslihan Turhan1, Linnea A Weiss, Narla Mohandas, Barry S Coller, Paul S Frenette.   

Abstract

Vascular occlusion is the major cause of morbidity and mortality in sickle cell disease but its mechanisms are poorly understood. We demonstrate by using intravital microscopy in mice expressing human sickle hemoglobin (SS) that SS red blood cells (RBCs) bind to adherent leukocytes in inflamed venules, producing vasoocclusion of cremasteric venules. SS mice deficient in P- and E-selectins, which display defective leukocyte recruitment to the vessel wall, are protected from vasoocclusion. These data uncover a previously unsuspected paradigm for the pathogenesis of sickle cell vasoocclusion in which adherent leukocytes play a direct role and suggest that drugs targeting SS RBC-leukocyte or leukocyte-endothelial interactions may prevent or treat the vascular complications of this debilitating disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880644      PMCID: PMC122470          DOI: 10.1073/pnas.052522799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  P-selectin mediates the adhesion of sickle erythrocytes to the endothelium.

Authors:  N M Matsui; L Borsig; S D Rosen; M Yaghmai; A Varki; S H Embury
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

2.  Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia.

Authors:  A P Grigg
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

3.  Fatal sickle cell crisis after granulocyte colony-stimulating factor administration.

Authors:  B K Adler; D E Salzman; M H Carabasi; W P Vaughan; V V Reddy; J T Prchal
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

4.  Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

Authors:  D K Kaul; R P Hebbel
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

5.  Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor.

Authors:  D K Kaul; H M Tsai; X D Liu; M T Nakada; R L Nagel; B S Coller
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

6.  On-line volume flow rate and velocity profile measurement for blood in microvessels.

Authors:  M Baker; H Wayland
Journal:  Microvasc Res       Date:  1974-01       Impact factor: 3.514

7.  Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates.

Authors:  H H Lipowsky; B W Zweifach
Journal:  Microvasc Res       Date:  1978-01       Impact factor: 3.514

8.  Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.

Authors:  R P Hebbel; O Yamada; C F Moldow; H S Jacob; J G White; J W Eaton
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

9.  Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures.

Authors:  R Hoover; R Rubin; G Wise; R Warren
Journal:  Blood       Date:  1979-10       Impact factor: 22.113

10.  Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells.

Authors:  J F Tait; C Smith
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

View more
  156 in total

1.  Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.

Authors:  Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Jeffrey C Kurz; Robert G Schaub; Tohru Ikuta; C Alvin Head
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

2.  Biography of Barry S. Coller.

Authors:  Christen Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

Review 3.  Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.

Authors:  Alexander Zarbock; Klaus Ley; Rodger P McEver; Andrés Hidalgo
Journal:  Blood       Date:  2011-10-20       Impact factor: 22.113

4.  Nucleation of sickle hemoglobin mixed with hemoglobin A: experimental and theoretical studies of hybrid-forming mixtures.

Authors:  Maria Rotter; Donna Yosmanovich; Robin W Briehl; Suzanna Kwong; Frank A Ferrone
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

5.  Quantifying the rheological and hemodynamic characteristics of sickle cell anemia.

Authors:  Huan Lei; George Em Karniadakis
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

6.  The microrheology of sickle hemoglobin gels.

Authors:  Mikhail N Zakharov; Alexey Aprelev; Matthew S Turner; Frank A Ferrone
Journal:  Biophys J       Date:  2010-08-09       Impact factor: 4.033

7.  GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice.

Authors:  Jungshan Chang; John T Patton; Arun Sarkar; Beat Ernst; John L Magnani; Paul S Frenette
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

Review 8.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

9.  Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease.

Authors:  Vicky Chaar; Julien Picot; Olivier Renaud; Pablo Bartolucci; Ruben Nzouakou; Dora Bachir; Frédéric Galactéros; Yves Colin; Caroline Le Van Kim; Wassim El Nemer
Journal:  Haematologica       Date:  2010-06-18       Impact factor: 9.941

10.  The Gut Microbiome Regulates Psychological-Stress-Induced Inflammation.

Authors:  Chunliang Xu; Sung Kyun Lee; Dachuan Zhang; Paul S Frenette
Journal:  Immunity       Date:  2020-07-30       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.